GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

G Medical Innovations Holdings GMVDF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2019

Revenue

$5.5m

FY2015FY2019

Net income

−$15.0m

FY2015FY2019

Free cash flow

−$6.7m

FY2015FY2019

Shareholders' equity

−$13.4m

FY2015FY2019

Income statement

Fiscal years

FY2019FY2018FY2017FY2016FY2015
Revenue$5.5m$3.1m$110,000——
Research and development$440,000$4.1m$3.5m$1.8m$1.0m
Operating income−$12.8m−$17.2m−$26.5m−$2.7m−$1.9m
Net income−$15.0m−$16.3m−$27.1m−$3.0m−$2.0m
Diluted earnings per share-6.78-8.24-20.19-2.25-1.48

Balance sheet

At each fiscal year end

FY2019FY2018FY2017FY2016FY2015
Total assets$8.8m$14.2m$21.5m$970,000$120,000
Cash and short-term investments—$2.6m$14.2m$750,000$50,000
Total liabilities$22.1m$20.8m$13.0m$4.5m$1.6m
Debt$10.6m$9.1m$4.8m$4.0m$1.4m
Shareholders' equity−$13.4m−$6.6m$8.5m−$3.5m−$1.5m
Shares outstanding2m2m1m1m1m

Cash flow

Fiscal years

FY2019FY2018FY2017FY2016FY2015
Cash from operations−$6.3m−$15.5m−$8.3m−$2.5m−$1.8m
Capital spending−$430,000−$2.4m−$1.5m−$90,000−$50,000
Free cash flow−$6.7m−$17.8m−$9.8m−$2.6m−$1.8m

Latest quarters

By quarter end

Jun 2021Jun 2020Dec 2019Jun 2019Dec 2018Jun 2018Dec 2017Jun 2017
Revenue$2.9m$2.0m$2.6m$2.9m$2.1m$1.0m$110,000—
Operating income−$4.3m−$4.6m−$6.0m−$6.8m−$7.9m−$9.3m−$5.2m−$21.3m
Net income−$4.7m−$4.9m−$8.2m−$6.8m−$7.8m−$8.5m−$5.3m−$21.7m
Diluted earnings per share-1.22-1.29-3.45-3.33-3.86-4.38-3.22-21.32
Cash from operations—−$2.0m−$1.0m−$4.0m−$6.0m−$9.0m−$5.0m−$2.0m
Capital spending—————−$2.0m−$1.0m—
Free cash flow—————−$11.0m−$6.0m—
Total assets$17.2m$8.4m$8.8m$11.6m$14.2m$13.8m$21.5m$12.4m
Cash and short-term investments$13.4m$540,000—$350,000$2.6m$3.2m$14.2m$12.0m
Debt$2.4m$4.3m$9.2m$6.6m$7.8m$4.1m$3.1m$2.1m
Shareholders' equity$3.4m−$6.8m−$13.4m−$6.8m−$6.6m$130,000$8.5m$3.3m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income68.7%——
Net income70.7%——

Share price return

Finished calendar years

20252024202320222021202020192018
Return300%227%-92%-94%370%131421%-27%-2%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 35-to-1 reverse split · 21 Nov 2022
  • 5-to-1 reverse split · 16 Jun 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.